GlassScriptPhysician profile
Eileen M Cassidy
NPI 1689619629
$3,571.00
in general payments reported to CMS, 2019-2025
39 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $443 · 2021: $643 · 2022: $671 · 2023: $588 · 2024: $382 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149 · Education: $87.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.46 |
| Education | $87.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $662.51 | 2019-2024 | Liletta, Lo Loestrin Fe |
| Aspira Women'S Health INC | $263.66 | 2022-2024 | Ova1 |
| Exeltis, USA INC. | $238.38 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $222.78 | 2019-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $194.16 | 2021-2025 | |
| Astellas Pharma US INC | $183.09 | 2019-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $172.77 | 2019-2024 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Bayer Healthcare Pharmaceuticals INC. | $170.68 | 2019-2022 | |
| Organon LLC | $148.49 | 2021-2024 | Nexplanon |
| Daiichi Sankyo INC. | $142.20 | 2019-2021 | |
| Biogen, INC. | $128.25 | 2024-2025 | Zurzuvae |
| Millicent US INC | $126.16 | 2022-2024 | Intrarosa, Femring |
| Merck Sharp & Dohme LLC | $98.09 | 2019-2023 | Gardasil 9 |
| Lupin INC. | $84.88 | 2019-2020 | |
| Pfizer INC. | $69.18 | 2023-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Cassidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.